Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Genmab A/S (GNMSF) had Weighted-Average Shares Outstanding (Diluted) of 61.99M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$925.00M |
|
$336.00M |
|
$57.00M |
|
$868.00M |
|
$565.00M |
|
$360.00M |
|
$63.00M |
|
$423.00M |
|
$423.00M |
|
$336.00M |
|
$336.00M |
|
$336.00M |
|
$336.00M |
|
$360.00M |
|
$376.00M |
|
61.77M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
61.99M |
$5.44 |
|
$5.42 |
|
| Balance Sheet Financials | |
$3.91B |
|
$152.00M |
|
$2.55B |
|
$6.46B |
|
$629.00M |
|
-- |
|
$533.00M |
|
$1.16B |
|
$5.30B |
|
$3.19B |
|
$5.30B |
|
64.15M |
|
| Cash Flow Statement Financials | |
$349.00M |
|
$-17.00M |
|
$-419.00M |
|
$1.38B |
|
$1.30B |
|
$-84.00M |
|
$58.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
93.84% |
|
38.92% |
|
38.92% |
|
-- |
|
45.73% |
|
36.32% |
|
$327.00M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
4.38 |
|
0.93 |
|
97.10 |
|
6.34% |
|
10.52% |
|
5.20% |
|
6.34% |
|
$82.64 |
|
$5.27 |
|
$5.63 |
|